Pertussis
Links
References
CDC. Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants. MMWR May 30, 2008; Vol 57, No RR-4; 001.
CDC. Preventing Tetanus, Diphtheria, and Pertussis Among ADULTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR December 15, 2006; Vol 55, No RR-17; 001.
CDC. Preventing Tetanus, Diphtheria, and Pertussis Among ADOLESCENTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR March 24, 2006; Vol 55, No RR-3; 001.
CDC. Pertussis--United States, 2001-2003. MMWR December 23, 2005; 54(50):1283-6.
CDC. Recommended Antimicrobial Agents for Treatment and Postexposure Prophylaxis of Pertussis. MMWR December 9, 2005; Vol 54, No RR-14; 001.
Cassiday P, Sanden GN, Heuvelman K, Mooi F, Bisgard K, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000; 182: 1402-1408.
CDC. Combination Vaccines for Childhood Immunization. MMWR May 14, 1999; Vol 48, No RR05;1.
CDC. Notice to readers: FDA approval of a fourth acellular pertussis vaccine for use among infants and young children. MMWR November 6, 1998; 47; 934-936.
CDC. Table III. Provisional cases of selected diseases preventable by vaccination, United States week ending December 19, 1998 (week 50). MMWR December 25, 1998; Vol 47, No 50.
CDC. Pertussis Vaccination: Use of Acellular Pertussis Vaccines Among Infants and Young Children... MMWR March 23, 1997; Vol 46, No RR07;001.
Davis SF, Strebel PM, Cochi SL, Zell ER, Hadler SC. Pertussis Surveillance – United States, 1989-1991. MMWR 1992; 41: 11-17.
CDC. Diphtheria, Tetanus, and Pertussis: Recommendations for Vaccine Use...MMWR August 8, 1991; Vol 40, No RR10;001.
|